CAS ID: | 1654725-02-6 |
Molecular Formula: | C16H20N4O3S |
Molecular Weight: | 348.4 g/mol |
Monoisotopic Mass: | 348.126 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | |
Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
ClinicalTrial ID | NCT02690519 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | February 24, 2016 | Last Verified | October 11, 2016 |
Sponsor | Galapagos NV |
Trial Record 2
ClinicalTrial ID | NCT02707562 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | March 14, 2016 | Last Verified | December 7, 2016 |
Sponsor | Galapagos NV |
PubChem: | 117857370 |
ChEMBL: |